Thomas Wilder, Director at ENDOLOGIX INC /DE/ (ELGX), sold 1,455 shares at $6.34 ($9K) on 2019-05-07, disclosed to the SEC on 2019-05-09.
Seasonal sale ($9k) by Director — this insider has traded ELGX in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PEN | SELL | 2025-08-13 | $179K | — | Filing → |
| PEN | SELL | 2025-04-04 | $192K | — | Filing → |
| PEN | SELL | 2025-04-02 | $190K | — | Filing → |